[HTML][HTML] Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from …

M Brisson, É Bénard, M Drolet, JA Bogaards… - The Lancet Public …, 2016 - thelancet.com
Background Modelling studies have been widely used to inform human papillomavirus
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …

[HTML][HTML] Mathematical modelling and prediction in infectious disease epidemiology

A Huppert, G Katriel - Clinical microbiology and infection, 2013 - Elsevier
We discuss to what extent disease transmission models provide reliable predictions. The
concept of prediction is delineated as it is understood by modellers, and illustrated by some …

Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)–associated cancers and HPV …

A Jemal, EP Simard, C Dorell, AM Noone… - Journal of the …, 2013 - academic.oup.com
Abstract Background The American Cancer Society (ACS), the Centers for Disease Control
and Prevention (CDC), the National Cancer Institute (NCI), and the North American …

Projected association of human papillomavirus vaccination with oropharynx cancer incidence in the US, 2020-2045

Y Zhang, C Fakhry, G D'Souza - JAMA oncology, 2021 - jamanetwork.com
Importance Oropharynx cancer (OPC) incidence has increased for several decades in the
US. It is unclear when and how this trend will be affected by current HPV vaccination trends …

[HTML][HTML] Human papillomavirus vaccination: the population impact

L Lee, SM Garland - F1000Research, 2017 - ncbi.nlm.nih.gov
We currently have the knowledge and experience to prevent much of human papillomavirus
(HPV)-related disease burden globally. In many countries where prophylactic HPV …

Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model–based analysis

N Van de Velde, MC Boily, M Drolet… - Journal of the …, 2012 - academic.oup.com
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a …

Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis

JA Bogaards, J Wallinga, RH Brakenhoff, CJLM Meijer… - bmj, 2015 - bmj.com
Objective To assess the reduction in the vaccine preventable burden of cancer in men if
boys are vaccinated along with girls against oncogenic human papillomavirus (HPV) …

[HTML][HTML] Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population

KT Simms, A Keane, DTN Nguyen, M Caruana… - Nature Medicine, 2023 - nature.com
Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate
cervical cancer as a public health problem. To support the strategy, the WHO published …

Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males

H Bergman, BS Buckley, G Villanueva… - Cochrane database …, 1996 - cochranelibrary.com
Background Uptake of human papillomavirus (HPV) vaccine remains low in many countries,
although the bivalent and quadrivalent HPV vaccines given as a three‐dose schedule are …

Modeling preventative strategies against human papillomavirus-related disease in developed countries

K Canfell, H Chesson, SL Kulasingam, J Berkhof… - Vaccine, 2012 - Elsevier
Over the last 5 years, prophylactic vaccination against human papillomavirus (HPV) in pre-
adolescent females has been introduced in most developed countries, supported by …